Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Hui-Li Wong

Showing results (1-10 of 81) with videos related to

Pageof 9
Sort By:
The Lancet. Gastroenterology & Hepatology|December 5, 2022
Low intensity treatment in metastatic colorectal cancerHui-Li Wong, Jeanne Tie
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 28, 2012
Does adjuvant chemotherapy in elderly patients with stage III colon cancer really save lives?Hui-li Wong, Peter Gibbs
Internal Medicine Journal|September 6, 2018
Bridging health access disparities among culturally and linguistically diverse cancer patients: an ongoing challengeChristine Semira, Hui-Li Wong, Peter Gibbs
Cancer Control : Journal of the Moffitt Cancer Center|November 10, 2025
Effectiveness of Chemotherapy Plus Immunotherapy and Molecular Alterations in Advanced Biliary Tract Cancer: Real-World Evidence From a Single-Center Australian CohortJirapat Wonglhow, Hui-Li Wong, Michael Michael
Expert Opinion on Pharmacotherapy|August 9, 2011
Vandetanib for the treatment of non-small-cell lung cancerHui-li Wong, Richard H de Boer
Internal Medicine Journal|August 23, 2021
Author replyMatthew Loft, Hui-Li Wong, Peter Gibbs
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 8, 2015
Problematic Use of Multiple Subgroup Analyses in Assessing the Impact of Aspirin in Prostate CancerMargaret Lee, Hui-Li Wong, Peter Gibbs
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 25, 2015
Risk-adjusted pathologic margin positivity rate: a problematic quality indicatorNatalie H Turner, Hui-Li Wong, Peter Gibbs
Internal Medicine Journal|August 23, 2021
Complete metabolic response following anaplastic lymphoma kinase (ALK) targeted therapy in a patient with adenocarcinoma of unknown primary with immunohistochemistry/fluorescence in situ hybridisation discordant ALK test resultsGrace Chazan, Danielle Forbes, Anand Murugasu, et al.
Prostate International|July 10, 2015
Docetaxel in very elderly men with metastatic castration-resistant prostate cancerHui-Li Wong, Sheau Wen Lok, Shirley Wong, et al.
Pageof 9

Showing results (1-10 of 81) with videos related to

Sort By:
Pageof 9
The Lancet. Gastroenterology & Hepatology|December 5, 2022
Low intensity treatment in metastatic colorectal cancerHui-Li Wong, Jeanne Tie
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 28, 2012
Does adjuvant chemotherapy in elderly patients with stage III colon cancer really save lives?Hui-li Wong, Peter Gibbs
Internal Medicine Journal|September 6, 2018
Bridging health access disparities among culturally and linguistically diverse cancer patients: an ongoing challengeChristine Semira, Hui-Li Wong, Peter Gibbs
Cancer Control : Journal of the Moffitt Cancer Center|November 10, 2025
Effectiveness of Chemotherapy Plus Immunotherapy and Molecular Alterations in Advanced Biliary Tract Cancer: Real-World Evidence From a Single-Center Australian CohortJirapat Wonglhow, Hui-Li Wong, Michael Michael
Expert Opinion on Pharmacotherapy|August 9, 2011
Vandetanib for the treatment of non-small-cell lung cancerHui-li Wong, Richard H de Boer
Internal Medicine Journal|August 23, 2021
Author replyMatthew Loft, Hui-Li Wong, Peter Gibbs
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 8, 2015
Problematic Use of Multiple Subgroup Analyses in Assessing the Impact of Aspirin in Prostate CancerMargaret Lee, Hui-Li Wong, Peter Gibbs
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 25, 2015
Risk-adjusted pathologic margin positivity rate: a problematic quality indicatorNatalie H Turner, Hui-Li Wong, Peter Gibbs
Internal Medicine Journal|August 23, 2021
Complete metabolic response following anaplastic lymphoma kinase (ALK) targeted therapy in a patient with adenocarcinoma of unknown primary with immunohistochemistry/fluorescence in situ hybridisation discordant ALK test resultsGrace Chazan, Danielle Forbes, Anand Murugasu, et al.
Prostate International|July 10, 2015
Docetaxel in very elderly men with metastatic castration-resistant prostate cancerHui-Li Wong, Sheau Wen Lok, Shirley Wong, et al.
Pageof 9